Pietzner, M.* ; Wheeler, E.* ; Carrasco-Zanini, J.* ; Raffler, J. ; Kerrison, N.D.* ; Oerton, E.* ; Auyeung, V.P.W.* ; Luan, J.* ; Finan, C.* ; Casas, J.P.* ; Ostroff, R.* ; Williams, S.A.* ; Kastenmüller, G. ; Ralser, M.* ; Gamazon, E.R.* ; Wareham, N.J.* ; Hingorani, A.D.* ; Langenberg, C.*
Genetic architecture of host proteins involved in SARS-CoV-2 infection.
Nat. Commun. 11:6397 (2020)
Understanding the genetic architecture of host proteins interacting with SARS-CoV-2 or mediating the maladaptive host response to COVID-19 can help to identify new or repurpose existing drugs targeting those proteins. We present a genetic discovery study of 179 such host proteins among 10,708 individuals using an aptamer-based technique. We identify 220 host DNA sequence variants acting in cis (MAF 0.01-49.9%) and explaining 0.3-70.9% of the variance of 97 of these proteins, including 45 with no previously known protein quantitative trait loci (pQTL) and 38 encoding current drug targets. Systematic characterization of pQTLs across the phenome identified protein-drug-disease links and evidence that putative viral interaction partners such as MARK3 affect immune response. Our results accelerate the evaluation and prioritization of new drug development programmes and repurposing of trials to prevent, treat or reduce adverse outcomes. Rapid sharing and detailed interrogation of results is facilitated through an interactive webserver (https://omicscience.org/apps/covidpgwas/).
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Association; Disease; Metaanalysis; Reveals; Traits; Target; Risk
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2020
Prepublished im Jahr
HGF-Berichtsjahr
2020
ISSN (print) / ISBN
2041-1723
e-ISSN
2041-1723
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 11,
Heft: 1,
Seiten: ,
Artikelnummer: 6397
Supplement: ,
Reihe
Verlag
Nature Publishing Group
Verlagsort
London
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30205 - Bioengineering and Digital Health
Forschungsfeld(er)
Enabling and Novel Technologies
PSP-Element(e)
G-503891-001
Förderungen
national "Covid-19 Cardiovascular Disease Flagship Projects"
Cambridge Trust
4-year Wellcome Trust PhD Studentship
Somalogic
University of Cambridge
National Institute on Aging (NIA)
National Institute for Health Research University College London Hospitals Biomedical Research Centre
UCL British Heart Foundation Research Accelerator Award
German Federal Ministry of Education and Research (BMBF)
National Human Genome Research Institute of the National Institutes of Health
Wellcome Trust
UK Medical Research Council
Francis Crick Institute from Cancer Research UK
Medical Research Council
Copyright
Erfassungsdatum
2021-02-06